BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 2435401)

  • 1.
    Kunc M; Gabrych A; Rekawiecki B; Gorczynski A; Franke S; Haybaeck J; Biernat W; Czapiewski P
    Contemp Oncol (Pozn); 2019; 23(4):202-207. PubMed ID: 31992951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
    Tseng JH; Bisogna M; Hoang LN; Olvera N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Levine DA; Jelinic P
    Sci Rep; 2017 Jun; 7(1):3614. PubMed ID: 28620240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship.
    Ardighieri L; Mori L; Conzadori S; Bugatti M; Falchetti M; Donzelli CM; Ravaggi A; Odicino FE; Facchetti F
    Virchows Arch; 2016 Jul; 469(1):61-9. PubMed ID: 27059324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin synergizes with 34.5ENVE to enhance antitumor efficacy against metastatic ovarian cancer.
    Bolyard C; Yoo JY; Wang PY; Saini U; Rath KS; Cripe TP; Zhang J; Selvendiran K; Kaur B
    Clin Cancer Res; 2014 Dec; 20(24):6479-94. PubMed ID: 25294909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapidly growing esophageal carcinosarcoma reduced by neoadjuvant radiotherapy alone.
    Ogasawara N; Tamura Y; Funaki Y; Yamaguchi Y; Shimozato A; Yanamoto K; Takahashi E; Miyachi M; Sasaki M; Kasugai K
    Case Rep Gastroenterol; 2014 May; 8(2):227-34. PubMed ID: 25076867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.
    Campos SM; Brady WE; Moxley KM; O'Cearbhaill RE; Lee PS; DiSilvestro PA; Rotmensch J; Rose PG; Thaker PH; O'Malley DM; Hanjani P; Zuna RE; Hensley ML
    Gynecol Oncol; 2014 Jun; 133(3):537-41. PubMed ID: 24594074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic aberrations of ovarian and uterine carcinosarcomas--a CGH and FISH study.
    Schipf A; Mayr D; Kirchner T; Diebold J
    Virchows Arch; 2008 Mar; 452(3):259-68. PubMed ID: 18193277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?
    McCluggage WG
    J Clin Pathol; 2002 May; 55(5):321-5. PubMed ID: 11986333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional culture of a mixed mullerian tumor of the ovary: expression of in vivo characteristics.
    Goodwin TJ; Prewett TL; Spaulding GF; Becker JL
    In Vitro Cell Dev Biol Anim; 1997 May; 33(5):366-74. PubMed ID: 9196895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary.
    Becker JL; Papenhausen PR; Widen RH
    In Vitro Cell Dev Biol Anim; 1997 May; 33(5):325-31. PubMed ID: 9196889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinosarcoma of the urinary bladder. A light, immunohistochemical and electron microscopical case report.
    Cross PA; Eyden BP; Joglekar VM
    Virchows Arch A Pathol Anat Histopathol; 1989; 415(1):91-5. PubMed ID: 2499982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histogenesis of ovarian malignant mixed mesodermal tumours.
    Clarke TJ
    J Clin Pathol; 1990 Apr; 43(4):287-90. PubMed ID: 2160478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunohistochemical profile of malignant mixed müllerian tumor. Overlap with endometrial adenocarcinoma.
    Meis JM; Lawrence WD
    Am J Clin Pathol; 1990 Jul; 94(1):1-7. PubMed ID: 1694389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spindle-cell carcinoma of the upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors.
    Zarbo RJ; Crissman JD; Venkat H; Weiss MA
    Am J Surg Pathol; 1986 Nov; 10(11):741-53. PubMed ID: 2430474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry.
    Deligdisch L; Plaxe S; Cohen CJ
    Int J Gynecol Pathol; 1988; 7(4):361-72. PubMed ID: 2466009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrauterine mixed mesodermal tumors. An immunohistochemical study.
    Dellers EA; Valente PT; Edmonds PR; Balsara G
    Arch Pathol Lab Med; 1991 Sep; 115(9):918-20. PubMed ID: 1718238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mixed müllerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations.
    Geisinger KR; Dabbs DJ; Marshall RB
    Cancer; 1987 May; 59(10):1781-90. PubMed ID: 2435401
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.